Not applicableEnrolling By InvitationNCT06685536What this trial is testingA Long-term Follow-up Study in Participants Who Received CS-101Who this might be right forBeta-Thalassemia CorrectSequence Therapeutics Co., Ltd 5
Not applicableStudy completedNCT00159042What this trial is testingGenetic Factors Affecting the Severity of Beta ThalassemiaWho this might be right forBeta Thalassemia Deborah Rund 50
Not applicableLooking for participantsNCT06418256What this trial is testingPhysiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion ExplorationsWho this might be right forSplenectomy Assistance Publique - Hôpitaux de Paris 100
Not applicableUnknownNCT05632289What this trial is testingOsteopathic Manipulation in the Management of Pain Associated With Sickel Cell DiseaseWho this might be right forSickle Cell Disease College Osteopathique de Provence Aix-Marseille 37
Early research (Phase 1)Study completedNCT02567682What this trial is testingDrug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy SubjectsWho this might be right forSickle Cell Disease Global Blood Therapeutics 24
Very early researchNot Yet RecruitingNCT07000318What this trial is testingCS-206 in Patients With Sickle Cell DiseaseWho this might be right forSickle Cell Disease Children's Hospital of Fudan University 5
Testing effectiveness (Phase 2)WithdrawnNCT04938635What this trial is testingEfficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemiaWho this might be right forBeta-Thalassemia Vifor (International) Inc.
Testing effectiveness (Phase 2)Study completedNCT00174538What this trial is testingCodeine in Sickle Cell DiseaseWho this might be right forSickle Cell Disease PriCara, Unit of Ortho-McNeil, Inc. 60
Large-scale testing (Phase 3)Study completedNCT03655678What this trial is testingA Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-ThalassemiaWho this might be right forBeta-ThalassemiaThalassemiaGenetic Diseases, Inborn+2 more Vertex Pharmaceuticals Incorporated 59
Not applicableStudy completedNCT02475993What this trial is testingSMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital DischargeWho this might be right forSickle Cell Disease Duke University 45
Not applicableEnded earlyNCT01141621What this trial is testingThe Dallas Hereditary Spherocytosis Cohort StudyWho this might be right forHereditary Spherocytosis University of Texas Southwestern Medical Center 55
Very early researchUnknownNCT05263817What this trial is testingA Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and VasculitisWho this might be right forPOEMS SyndromeAmyloidosisAutoimmune Hemolytic Anemia+1 more Zhejiang University 75
Early research (Phase 1)Study completedNCT03673085What this trial is testingClinical Study of CN128 in Thalassemia PatientsWho this might be right forThalassemia Hangzhou Zede Pharma-Tech Co., Ltd. 32
Testing effectiveness (Phase 2)Ended earlyNCT01363908What this trial is testingSafety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron OverloadWho this might be right forTransfusional Iron OverloadBeta-Thalassemia Shire 30
Not applicableUnknownNCT06300723What this trial is testingClinical Study of BRL-101 in Severe SCDWho this might be right forSickle Cell Disease Bioray Laboratories 3
Testing effectiveness (Phase 2)Study completedNCT03805581What this trial is testingDefibrotide in Sickle Cell Disease-Related Acute Chest SyndromeWho this might be right forSickle Cell DiseaseAcute Chest Syndrome New York Medical College 20
Testing effectiveness (Phase 2)Study completedNCT00600938What this trial is testingEvaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron OverloadWho this might be right forTransfusional Iron OverloadTransfusional Hemosiderosis Novartis Pharmaceuticals 197
Testing effectiveness (Phase 2)Study completedNCT00502788What this trial is testingEvaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)Who this might be right forHepatitis CThalassemia Carelon Research 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03692052What this trial is testingDetermine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent ThalassemiaWho this might be right forThalassemia Agios Pharmaceuticals, Inc. 20
Not applicableUnknownNCT03951818What this trial is testingObserving the Changes of Endocrine and Metabolism in Patients With Thalassemia MajorWho this might be right forThalassemia Major National Taiwan University Hospital 100